1W08 - JenaLib

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:130
 aligned with LYSC_HUMAN | P61626 from UniProtKB/Swiss-Prot  Length:148

    Alignment length:130
                                    28        38        48        58        68        78        88        98       108       118       128       138       148
           LYSC_HUMAN    19 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 148
               SCOP domains d1w08a_ A: Lysozyme                                                                                                                SCOP domains
               CATH domains 1w08A00 A:1-130  [code=1.10.530.10, no name defined]                                                                               CATH domains
               Pfam domains Lys-1w08A01 A:1-128                                                                                                             -- Pfam domains
         Sec.struct. author ...hhhhhhhhhhhh........hhhhhhhhhhhhhh.....eee......eee....ee....................hhhhh...hhhhhhhhhhhh...hhhhhhhhhhhhh....hhhhh..... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------T----------H--N------------------------------------------------------------ SAPs(SNPs)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) LACTALBUMIN_LYSOZYME_2  PDB: A:1-130 UniProt: 19-148                                                                               PROSITE (3)
                PROSITE (4) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (4)
                PROSITE (5) ----------------------------------------------------------------------------LACTALBUMIN_LYSOZYM----------------------------------- PROSITE (5)
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------- Transcript
                 1w08 A   1 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKNPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 130
                                    10        20        30        40        50        60        70        80        90       100       110       120       130

Chain A from PDB  Type:PROTEIN  Length:130
 aligned with LYSC_PANPA | P61627 from UniProtKB/Swiss-Prot  Length:148

    Alignment length:130
                                    28        38        48        58        68        78        88        98       108       118       128       138       148
           LYSC_PANPA    19 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 148
               SCOP domains d1w08a_ A: Lysozyme                                                                                                                SCOP domains
               CATH domains 1w08A00 A:1-130  [code=1.10.530.10, no name defined]                                                                               CATH domains
               Pfam domains Lys-1w08A01 A:1-128                                                                                                             -- Pfam domains
         Sec.struct. author ...hhhhhhhhhhhh........hhhhhhhhhhhhhh.....eee......eee....ee....................hhhhh...hhhhhhhhhhhh...hhhhhhhhhhhhh....hhhhh..... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------T----------H--N------------------------------------------------------------ SAPs(SNPs)
                PROSITE (1) LACTALBUMIN_LYSOZYME_2  PDB: A:1-130 UniProt: 19-148                                                                               PROSITE (1)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (3)
                PROSITE (4) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (4)
                PROSITE (5) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (5)
                PROSITE (6) ----------------------------------------------------------------------------LACTALBUMIN_LYSOZYM----------------------------------- PROSITE (6)
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------- Transcript
                 1w08 A   1 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKNPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 130
                                    10        20        30        40        50        60        70        80        90       100       110       120       130

Chain A from PDB  Type:PROTEIN  Length:130
 aligned with LYSC_PANTR | P61628 from UniProtKB/Swiss-Prot  Length:148

    Alignment length:130
                                    28        38        48        58        68        78        88        98       108       118       128       138       148
           LYSC_PANTR    19 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKTPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 148
               SCOP domains d1w08a_ A: Lysozyme                                                                                                                SCOP domains
               CATH domains 1w08A00 A:1-130  [code=1.10.530.10, no name defined]                                                                               CATH domains
               Pfam domains Lys-1w08A01 A:1-128                                                                                                             -- Pfam domains
         Sec.struct. author ...hhhhhhhhhhhh........hhhhhhhhhhhhhh.....eee......eee....ee....................hhhhh...hhhhhhhhhhhh...hhhhhhhhhhhhh....hhhhh..... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------T----------H--N------------------------------------------------------------ SAPs(SNPs)
                PROSITE (2) LACTALBUMIN_LYSOZYME_2  PDB: A:1-130 UniProt: 19-148                                                                               PROSITE (2)
                PROSITE (3) ---------------------------------------------------------------------------------------------------------------------------------- PROSITE (3)
                PROSITE (4) ----------------------------------------------------------------------------LACTALBUMIN_LYSOZYM----------------------------------- PROSITE (4)
                 Transcript ---------------------------------------------------------------------------------------------------------------------------------- Transcript
                 1w08 A   1 KVFERCELARTLKRLGMDGYRGISLANWMCLAKWESGYNTRATNYNAGDRSTDYGIFQINSRYWCNDGKNPGAVNACHLSCSALLQDNIADAVACAKRVVRDPQGIRAWVAWRNRCQNRDVRQYVQGCGV 130
                                    10        20        30        40        50        60        70        80        90       100       110       120       130

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (1, 1)

CATH Domains (1, 1)

Pfam Domains (1, 1)

Gene Ontology (14, 30)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (LYSC_HUMAN | P61626)

molecular function
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016798	hydrolase activity, acting on glycosyl bonds	Catalysis of the hydrolysis of any glycosyl bond.
	GO:0042802	identical protein binding	Interacting selectively and non-covalently with an identical protein or proteins.
	GO:0003796	lysozyme activity	Catalysis of the hydrolysis of the beta-(1->4) linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan.
biological process
	GO:0044267	cellular protein metabolic process	The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification.
	GO:0019835	cytolysis	The rupture of cell membranes and the loss of cytoplasm.
	GO:0042742	defense response to bacterium	Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
	GO:0006954	inflammatory response	The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0001895	retina homeostasis	A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function.
cellular component
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

Chain A (LYSC_PANPA | P61627)

molecular function
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016798	hydrolase activity, acting on glycosyl bonds	Catalysis of the hydrolysis of any glycosyl bond.
	GO:0003796	lysozyme activity	Catalysis of the hydrolysis of the beta-(1->4) linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan.
biological process
	GO:0019835	cytolysis	The rupture of cell membranes and the loss of cytoplasm.
	GO:0042742	defense response to bacterium	Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
cellular component
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

Chain A (LYSC_PANTR | P61628)

molecular function
	GO:0003824	catalytic activity	Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016798	hydrolase activity, acting on glycosyl bonds	Catalysis of the hydrolysis of any glycosyl bond.
	GO:0003796	lysozyme activity	Catalysis of the hydrolysis of the beta-(1->4) linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in a peptidoglycan.
biological process
	GO:0019835	cytolysis	The rupture of cell membranes and the loss of cytoplasm.
	GO:0042742	defense response to bacterium	Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
cellular component
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File

133l	LYSOZYME MUTANT WITH ARG 115 REPLACED BY HIS (R115H)
134l	LYSOZYME MUTANT WITH ARG 115 REPLACED BY GLU (R115E)
1b5u	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANT
1b5v	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANTS
1b5w	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANTS
1b5x	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANTS
1b5y	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANTS
1b5z	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME: CALORIMETRY AND X-RAY ANALYSIS OF SIX SER ->ALA MUTANTS
1b7l	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7m	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7n	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7o	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7p	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7q	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7r	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1b7s	VERIFICATION OF SPMP USING MUTANT HUMAN LYSOZYMES
1bb3	HUMAN LYSOZYME MUTANT A96L
1bb4	HUMAN LYSOZYME DOUBLE MUTANT A96L, W109H
1bb5	HUMAN LYSOZYME MUTANT A96L COMPLEXED WITH CHITOTRIOSE
1c43	MUTANT HUMAN LYSOZYME WITH FOREIGN N- TERMINAL RESIDUES
1c45	MUTANT HUMAN LYSOZYME WITH FOREIGN N- TERMINAL RESIDUES
1c46	MUTANT HUMAN LYSOZYME WITH FOREIGN N- TERMINAL RESIDUES
1c7p	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME WITH FOUR EXTRA RESIDUES (EAEA) AT THE N- TERMINAL
1cj6	T11A MUTANT HUMAN LYSOZYME
1cj7	T11V MUTANT HUMAN LYSOZYME
1cj8	T40A MUTANT HUMAN LYSOZYME
1cj9	T40V MUTANT HUMAN LYSOZYME
1ckc	T43A MUTANT HUMAN LYSOZYME
1ckd	T43V MUTANT HUMAN LYSOZYME
1ckf	T52A MUTANT HUMAN LYSOZYME
1ckg	T52V MUTANT HUMAN LYSOZYME
1ckh	T70V MUTANT HUMAN LYSOZYME
1d6p	HUMAN LYSOZYME L63 MUTANT LABELLED WITH 2', 3'-EPOXYPROPYL N, N'-DIACETYLCHITOBIOSE
1d6q	HUMAN LYSOZYME E102 MUTANT LABELLED WITH 2', 3'-EPOXYPROPYL GLYCOSIDE OF N- ACETYLLACTOSAMINE
1di3	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME
1di4	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME
1di5	ROLE OF AMINO ACID RESIDUES AT TURNS IN THE CONFORMATIONAL STABILITY AND FOLDING OF HUMAN LYSOZYME
1eq4	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME
1eq5	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME
1eqe	CRYSTAL STRUCTURES OF SALT BRIDGE MUTANTS OF HUMAN LYSOZYME
1gay	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gaz	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb0	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb2	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb3	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb5	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb6	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb7	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb8	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gb9	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gbo	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gbw	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gbx	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gby	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gbz	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gdw	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1gdx	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1ge0	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1ge1	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1ge2	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1ge3	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1ge4	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATLEFT-HANDED HELICAL POSITIONS
1gev	BURIED POLAR MUTANT HUMAN LYSOZYME
1gez	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf0	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf3	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf4	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf5	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf6	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf7	BURIED POLAR MUTANT HUMAN LYSOZYME
1gf8	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gf9	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfa	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfe	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfg	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfh	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfj	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfk	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfr	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gft	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfu	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1gfv	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1hnl	LYSOZYME MUTANT WITH CYS 77 REPLACED BY ALA (C77A) COMPLEXED WITH GLUTATHIONE
1i1z	MUTANT HUMAN LYSOZYME (Q86D)
1i20	MUTANT HUMAN LYSOZYME (A92D)
1i22	MUTANT HUMAN LYSOZYME (A83K/Q86D/A92D)
1inu	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME SUBSTITUTED ATTHE SURFACE POSITIONS
1ioc	CRYSTAL STRUCTURE OF MUTANT HUMAN LYSOZYME, EAEA-I56T
1ip1	G37A HUMAN LYSOZYME
1ip2	G48A HUMAN LYSOZYME
1ip3	G68A HUMAN LYSOZYME
1ip4	G72A HUMAN LYSOZYME
1ip5	G105A HUMAN LYSOZYME
1ip6	G127A HUMAN LYSOZYME
1ip7	G129A HUMAN LYSOZYME
1iwt	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 113K.
1iwu	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 127K.
1iwv	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 147K.
1iww	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 152K.
1iwx	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 161K.
1iwy	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 170K.
1iwz	CRYSTAL STRUCTURE ANALYSIS OF HUMAN LYSOZYME AT 178K.
1ix0	I59A-3SS HUMAN LYSOZYME
1iy3	SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 4 DEGREE C
1iy4	SOLUTION STRUCTURE OF THE HUMAN LYSOZYME AT 35 DEGREE C
1jka	HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ASP
1jkb	HUMAN LYSOZYME MUTANT WITH GLU 35 REPLACED BY ALA
1jkc	HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY PHE
1jkd	HUMAN LYSOZYME MUTANT WITH TRP 109 REPLACED BY ALA
1jsf	FULL-MATRIX LEAST-SQUARES REFINEMENT OF HUMAN LYSOZYME
1jwr	CRYSTAL STRUCTURE OF HUMAN LYSOZYME AT 100K
1laa	LYSOZYME MUTANT WITH ASP 53 REPLACED BY GLU (D53E)
1lhh	LYSOZYME MUTANT WITH VAL 110 REPLACED BY PRO (V110P)
1lhi	LYSOZYME MUTANT WITH PRO 71 REPLACED BY GLY (P71G)
1lhj	LYSOZYME MUTANT WITH PRO 103 REPLACED BY GLY (P103G)
1lhk	LYSOZYME MUTANT WITH ASP 91 REPLACED BY PRO (D91P)
1lhl	LYSOZYME MUTANT WITH ALA 47 REPLACED BY PROLINE (A47P)
1lhm	LYSOZYME (MUTANT WITH CYS 77 REPLACED BY ALA AND CYS 95 REPLACED BY ALA) (C77A, C95A)
1lmt	LYSOZYME (LZ_CRGD4) MUTANT WITH CYS-ARG-GLY -ASP-SER-CYS INSERTED BETWEEN VAL 74 AND ASN 75 (INS(74-CRFDSC-75) COMPLEXED WITH TRI-ACETYL-CHITOTRIOSE
1loz	AMYLOIDOGENIC VARIANT (I56T) VARIANT OF HUMAN LYSOZYME
1lyy	AMYLOIDOGENIC VARIANT (ASP67HIS) OF HUMAN LYSOZYME
1lz1	LYSOZYME
1lz4	LYSOZYME MUTANT WITH CYS 77 REPLACED BY ALA (C77A)
1lz5	LYSOZYME MUTANT WITH FOUR AMINO ACID RESIDUES (ARG 74A, GLY 74B, ASP 74C AND SER 74D) INSERTED BETWEEN VAL 74 AND ASN 75
1lz6	LYSOZYME MUTANT WITH EIGHT AMINO ACID RESIDUES (THR 74A, GLY 74B, ARG 74C, GLY 74D, ASP 74E, SER 74F, PRO 74G AND ALA 74H) INSERTED BETWEEN VAL 74 AND ASN 75
1lzr	LYSOZYME (LZ406) COMPLEXED WITH TETRA-ACETYL- CHITOTETRAOSE
1lzs	LYSOZYME (LZ604) COMPLEXED WITH N- ACETYLCHITOSE OLIGOMERS
1op9	COMPLEX OF HUMAN LYSOZYME WITH CAMELID VHH HL6 ANTIBODYFRAGMENT
1oua	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE I56T MUTANT
1oub	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V100A MUTANT
1ouc	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V110A MUTANT
1oud	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V121A MUTANT
1oue	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V125A MUTANT
1ouf	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V130A MUTANT
1oug	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V2A MUTANT
1ouh	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V74A MUTANT
1oui	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V93A MUTANT
1ouj	CONTRIBUTION OF HYDROPHOBIC RESIDUES TO THE STABILITY OF HUMAN LYSOZYME: X-RAY STRUCTURE OF THE V99A MUTANT
1qsw	CRYSTAL STRUCTURE ANALYSIS OF A HUMAN LYSOZYME MUTANT W64CC65A
1re2	HUMAN LYSOZYME LABELLED WITH TWO 2',3'- EPOXYPROPYL BETA- GLYCOSIDE OF N- ACETYLLACTOSAMINE
1rem	HUMAN LYSOZYME WITH MAN-B1,4-GLCNAC COVALENTLY ATTACHED TO ASP53
1rex	NATIVE HUMAN LYSOZYME
1rey	HUMAN LYSOZYME-N,N'-DIACETYLCHITOBIOSE COMPLEX
1rez	HUMAN LYSOZYME-N-ACETYLLACTOSAMINE COMPLEX
1tay	LYSOZYME MUTANT WITH TYR 63 REPLACED BY ALA (Y63A)
1tby	LYSOZYME MUTANT WITH TYR 63 REPLACED BY LEU (Y63L)
1tcy	LYSOZYME MUTANT WITH TYR 63 REPLACED BY PHE (Y63F)
1tdy	LYSOZYME MUTANT WITH TYR 63 REPLACED BY TRP (Y63W)
1ubz	CRYSTAL STRUCTURE OF GLU102-MUTANT HUMAN LYSOZYME DOUBLYLABELED WITH 2',3'-EPOXYPROPYL BETA-GLYCOSIDE OF N-ACETYLLACTOSAMINE
1wqm	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1wqn	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1wqo	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1wqp	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1wqq	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1wqr	CONTRIBUTION OF HYDROGEN BONDS TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
1yam	MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: NULL; EC: 3.2.1.17; ENGINEERED: YES; MUTATION: I106V
1yan	MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: NULL; EC: 3.2.1.17; ENGINEERED: YES; MUTATION: I23V
1yao	MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: NULL; EC: 3.2.1.17; ENGINEERED: YES; MUTATION: I56V
1yap	MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: NULL; EC: 3.2.1.17; ENGINEERED: YES; MUTATION: I59V
1yaq	MOL_ID: 1; MOLECULE: LYSOZYME; CHAIN: NULL; EC: 3.2.1.17; ENGINEERED: YES; MUTATION: I89V
207l	MUTANT HUMAN LYSOZYME C77A
208l	MUTANT HUMAN LYSOZYME C77A
2bqa	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqb	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqc	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqd	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqe	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqf	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqg	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqh	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqi	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqj	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqk	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bql	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqm	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqn	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2bqo	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2hea	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2heb	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2hec	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2hed	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2hee	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2hef	CONTRIBUTION OF WATER MOLECULES IN THE INTERIOR OFA PROTEIN TO THE CONFORMATIONAL STABILITY
2lhm	LYSOZYME (APO) (MUTANT WITH GLN 86 REPLACED B ASP AND ALA 92 REPLACED BY ASP) (Q86D,A92D)
2mea	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS
2meb	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS
2mec	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS
2med	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2mee	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2mef	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2meg	CHANGES IN CONFORMATIONAL STABILITY OF A SERIES OF MUTANT HUMAN LYSOZYMES AT CONSTANT POSITIONS.
2meh	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
2mei	CONTRIBUTION OF HYDROPHOBIC EFFECT TO THE CONFORMATIONAL STABILITY OF HUMAN LYSOZYME
3lhm	LYSOZYME (HOLO) (MUTANT WITH GLN 86 REPLACED BY ASP AND ALA 92 REPLACED BY ASP) (Q86D,A92D)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (1, 1)

Sites (1, 1)

SS Bonds (4, 4)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (3, 3)

PROSITE Motifs (2, 2)

Exons (0, 0)

Sequences/Alignments